PlainRecalls
FDA Drug Low Class III Terminated

Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-435-01.

Reported: January 12, 2022 Initiated: December 22, 2021 #D-0326-2022

Product Description

Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-435-01.

Reason for Recall

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Details

Units Affected
50,832 bottles
Distribution
Nationwide in the USA and Puerto Rico
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-435-01.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 50,832 bottles.
Why was this product recalled?
Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 12, 2022. Severity: Low. Recall number: D-0326-2022.